260 related articles for article (PubMed ID: 30796939)
1. Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study.
Mavrogianni C; Lambrinou CP; Androutsos O; Lindström J; Kivelä J; Cardon G; Huys N; Tsochev K; Iotova V; Chakarova N; Rurik I; Moreno LA; Liatis S; Makrilakis K; Manios Y;
Diabetes Res Clin Pract; 2019 Apr; 150():99-110. PubMed ID: 30796939
[TBL] [Abstract][Full Text] [Related]
2. Two-stage, school and community-based population screening successfully identifies individuals and families at high-risk for type 2 diabetes: the Feel4Diabetes-study.
Manios Y; Mavrogianni C; Lambrinou CP; Cardon G; Lindström J; Iotova V; Tankova T; Civeira F; Kivelä J; Jancsó Z; Shadid S; Tsochev K; Mateo-Gallego R; Radó S; Dafoulas G; Makrilakis K; Androutsos O;
BMC Endocr Disord; 2020 Mar; 20(Suppl 1):12. PubMed ID: 32164646
[TBL] [Abstract][Full Text] [Related]
3. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
[TBL] [Abstract][Full Text] [Related]
4. Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population.
Rokhman MR; Arifin B; Zulkarnain Z; Satibi S; Perwitasari DA; Boersma C; Postma MJ; van der Schans J
PLoS One; 2022; 17(7):e0269853. PubMed ID: 35862370
[TBL] [Abstract][Full Text] [Related]
5. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
[TBL] [Abstract][Full Text] [Related]
6. Predictors of undiagnosed prevalent type 2 diabetes - The Danish General Suburban Population Study.
Heltberg A; Andersen JS; Sandholdt H; Siersma V; Kragstrup J; Ellervik C
Prim Care Diabetes; 2018 Feb; 12(1):13-22. PubMed ID: 28964672
[TBL] [Abstract][Full Text] [Related]
7. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care.
Lim HM; Chia YC; Koay ZL
Prim Care Diabetes; 2020 Oct; 14(5):494-500. PubMed ID: 32156516
[TBL] [Abstract][Full Text] [Related]
8. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
Salinero-Fort MÁ; de Burgos-Lunar C; Mostaza Prieto J; Lahoz Rallo C; Abánades-Herranz JC; Gómez-Campelo P; Laguna Cuesta F; Estirado De Cabo E; García Iglesias F; González Alegre T; Fernández Puntero B; Montesano Sánchez L; Vicent López D; Cornejo Del Río V; Fernández García PJ; Sabín Rodríguez C; López López S; Patrón Barandío P;
BMJ Open; 2015 Jul; 5(7):e007195. PubMed ID: 26220868
[TBL] [Abstract][Full Text] [Related]
9. Performance of a Finnish Diabetes Risk Score in detecting undiagnosed diabetes among Kenyans aged 18-69 years.
Mugume IB; Wafula ST; Kadengye DT; Van Olmen J
PLoS One; 2023; 18(4):e0276858. PubMed ID: 37186010
[TBL] [Abstract][Full Text] [Related]
10. Sociodemographic, anthropometric, and lifestyle correlates of prediabetes and type 2 diabetes in europe: The Feel4Diabetes study.
Kontochristopoulou AM; Karatzi K; Karaglani E; Cardon G; Kivelä J; Wikström K; Iotova V; Tsochev K; Tankova T; Rurik I; Radone AS; Liatis S; Makrilakis K; Moreno LA; Manios Y
Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1851-1862. PubMed ID: 35610084
[TBL] [Abstract][Full Text] [Related]
11. Choosing the most appropriate existing type 2 diabetes risk assessment tool for use in the Philippines: a case-control study with an urban Filipino population.
Agarwal G; Guingona MM; Gaber J; Angeles R; Rao S; Cristobal F
BMC Public Health; 2019 Aug; 19(1):1169. PubMed ID: 31455247
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
Vandersmissen GJ; Godderis L
Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
[TBL] [Abstract][Full Text] [Related]
13. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.
Arnardóttir E; Sigurðardóttir ÁK; Graue M; Kolltveit BH; Skinner T
BMC Public Health; 2023 Jan; 23(1):211. PubMed ID: 36721135
[TBL] [Abstract][Full Text] [Related]
14. Validation of DIABSCORE in screening for Type 2 Diabetes and prediabetes in Tunisian population.
Gannar F; Rodriguez-Pérez MDC; Domínguez Coello S; Haouet K; Brito Díaz B; Cabrera de León A
PLoS One; 2018; 13(8):e0200718. PubMed ID: 30110336
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe.
Gabriel R; Acosta T; Florez K; Anillo L; Navarro E; Boukichou N; Acosta-Reyes J; Barengo NC; Lindström J; Tuomilehto JO; Aschner P
Diabetes Res Clin Pract; 2021 Aug; 178():108976. PubMed ID: 34302911
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population.
Jin S; Chen Q; Han X; Liu Y; Cai M; Yao Z; Lu H
Front Endocrinol (Lausanne); 2022; 13():725314. PubMed ID: 35273562
[TBL] [Abstract][Full Text] [Related]
17. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
[TBL] [Abstract][Full Text] [Related]
18. [FINDRISC as screening for detection of prediabetes and unknown type 2 diabetes].
Peralta HM; Costa Gil JE; Saleme AE
Medicina (B Aires); 2024; 84(1):1-10. PubMed ID: 38271927
[TBL] [Abstract][Full Text] [Related]
19. Screening of undiagnosed hyperglycaemia in the dental setting: The DiabetRisk study. A field trial.
Montero E; Matesanz P; Nobili A; Luis Herrera-Pombo J; Sanz M; Guerrero A; Bujaldón A; Herrera D;
J Clin Periodontol; 2021 Mar; 48(3):378-388. PubMed ID: 33263197
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
Makrilakis K; Liatis S; Grammatikou S; Perrea D; Stathi C; Tsiligros P; Katsilambros N
Diabetes Metab; 2011 Apr; 37(2):144-51. PubMed ID: 21144787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
